Fulgent Genetics Inc Cash Flow Reinvestment Rate
Fulgent Genetics Inc cash flow reinvestment rate. Fulgent Genetics Inc (FLGT) has a Cash Flow Reinvestment Rate of 10.84x as of March 2026, reinvesting $76.90 Million (capex $5.20 Million plus investments $71.70 Million) from operating cash flow of $7.10 Million. Explore Fulgent Genetics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Fulgent Genetics Inc (2016–2024)
Cash flow reinvestment rate of Fulgent Genetics Inc from 2016 to 2024. Historical reinvestment intensity for Fulgent Genetics Inc across 8 annual periods. Explore Fulgent Genetics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Fulgent Genetics Inc Cash Flow Reinvestment Rate by Year (2016–2024)
Fulgent Genetics Inc cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Fulgent Genetics Inc. For the full cash flow conversion analysis, see FLGT cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.69x | $98.67 Million | $21.06 Million | $40.31 Million | ▲ +107.0% |
| 2023 | 2.26x | $61.10 Million | $27.00 Million | $22.21 Million | ▲ +104.8% |
| 2022 | 1.10x | $280.09 Million | $253.52 Million | $18.77 Million | ▲ +22.7% |
| 2021 | 0.90x | $484.74 Million | $538.58 Million | $23.84 Million | ▼ -61.2% |
| 2020 | 2.32x | $326.45 Million | $140.63 Million | $36.51 Million | ▼ -55.9% |
| 2019 | 5.26x | $29.05 Million | $5.52 Million | $1.18 Million | ▼ -19.1% |
| 2017 | 6.51x | $8.66 Million | $1.33 Million | $5.36 Million | ▼ -38.5% |
| 2016 | 10.58x | $46.58 Million | $4.41 Million | $3.79 Million | — |